Methodological limitations of economic evaluations of antenatal screening
- 11 September 2001
- journal article
- review article
- Published by Wiley in Health Economics
- Vol. 10 (8) , 775-778
- https://doi.org/10.1002/hec.636
Abstract
A review of recent economic studies of antenatal screening reveals widespread violation of accepted economic evaluation methodology. In particular, the costs and benefits of antenatal screening are often misclassified and conflated, and the non‐resource effects of averted costs are often excluded from the evaluation process. The result is a widespread violation of the explicit and systematic approaches taken by economic analysts more generally, and conclusions that may be described as misleading. This letter calls for economic analysts to be consistent in their application of economic evaluation methodology to antenatal screening programmes. Copyright © 2001 John Wiley & Sons, Ltd.Keywords
This publication has 19 references indexed in Scilit:
- Management of the presumed susceptible varicella (chickenpox)-exposed gravida: A cost-effectiveness / cost-benefit analysisPublished by Wolters Kluwer Health ,1999
- Prenatal Screening for Cystic Fibrosis Carriers: An Economic EvaluationAmerican Journal of Human Genetics, 1998
- A Cost-Effectiveness Analysis of Prenatal Carrier Screening for Cystic FibrosisPublished by Wolters Kluwer Health ,1998
- Decision Making with Respect to Diagnostic TestingMedical Decision Making, 1996
- Willingness to pay for antenatal carrier screening for cystic fibrosisHealth Economics, 1995
- Sometimes sensitive, seldom specific: A review of the economics of screeningHealth Economics, 1993
- A cost benefit analysis of genetic amniocentesisPublished by Wiley ,1993
- Costs and Benefits of Prenatal Screening for Cystic FibrosisMedical Care, 1991
- Applications of cost-benefit analysis to health careJournal of Health Economics, 1987
- Perspectives in spina bifidaBMJ, 1978